Testing has never been the main game, it's about vaccination of the whole global population that's where big pharma makes profits. Think about any other vaccination campaign after everyone has been vaccinated how many times do people get tested? Normally it is after they get sick not before they show symptoms.
New entrants are moving very fast and Ado just might get left behind?
Anyway there's another player ahead of the pack Sotarius.
Nanotechnology experts from RMIT University have collaborated with Melbourne company Soterius to develop a wearable COVID-19 detection disc.
Saliva competition, page-14
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.003(11.5%) |
Mkt cap ! $72.20M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.7¢ | 2.9¢ | $1.433M | 44.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 870964 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 511263 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |